| parent | Erythromycin+sulfiSOXAZOLE | LP15602-3 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] | 18920-9 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) | 238-6 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip | 11576-6 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | 237-8 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) | 236-0 |
| parent | Erythromycin+sulfiSOXAZOLE | LP15602-3 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] | 18920-9 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) | 238-6 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip | 11576-6 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | 237-8 |
| child | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) | 236-0 |
| PartDisplayName | en-US | Erythromycin+Sulfisoxazole | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR